Vaccine therapies for glioma: clinical frontiers and potential breakthrough
Glioma, the most common primary malignant brain tumor, is characterized by high recurrence and mortality rates. Its effective treatment remains a therapeutic challenge in clinical neuro-oncology. Despite over twenty years of exploring new therapies for glioma, progress in improving patient survival...
Saved in:
| Main Authors: | Ying Xing, Caixia Liu, Yunfeng Feng, Shangyu Li, Yuping Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1613332/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer
by: Yukari Ando, et al.
Published: (2025-04-01) -
Targeted Delivery of Personalized Cancer Vaccines Based on Antibody–Antigen Complexes
by: Yaling Zhang, et al.
Published: (2025-03-01) -
Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy
by: Yufei Lu, et al.
Published: (2025-04-01) -
mRNA vaccines in the context of cancer treatment: from concept to application
by: Qiang Fu, et al.
Published: (2025-01-01) -
Neoantigen prioritization based on antigen processing and presentation
by: Serina Tokita, et al.
Published: (2024-11-01)